Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|July 21, 2004
Prognostic factors in malignant mesotheliomaJacobus A Burgers, Ronald A M Damhuis
Translational Lung Cancer Research|November 14, 2025
Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic reviewIllaa Smesseim, Jo Raskin, Jacobus A Burgers
JTO Clinical and Research Reports|June 23, 2025
Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case SeriesIllaa Smesseim, Paul Baas, Jacobus A Burgers
The European Respiratory Journal|December 3, 2011
Population-based survival for malignant mesothelioma after introduction of novel chemotherapyRonald A M Damhuis, Caroline Schroten, Jacobus A Burgers
Scientific Reports|July 15, 2025
Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The NetherlandsIllaa Smesseim, Li-Anne H Douma, Jacobus A Burgers, et al.
Cancer|August 28, 2025
The legend of the response evaluation criteria in solid tumors: A historical overviewIllaa Smesseim, Kevin B W Groot Lipman, Ferry Lalezari, et al.
British Journal of Clinical Pharmacology|September 2, 2022
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept studyRené J Boosman, Nikki de Rouw, Alwin D R Huitema, et al.
Respiratory Medicine Case Reports|February 21, 2025
A three dimensional printed endobronchial stent for the treatment of a broncho-esophageal fistulaIllaa Smesseim, Sophia van Beelen, Jolanda M van Dieren, et al.
Anticancer Research|September 12, 2013
The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive reviewChristel C L M Boons, Maurits W VAN Tulder, Jacobus A Burgers, et al.
Pageof 6